Is endocan a biochemical marker for asymptomatic target organ damage in hypertensive patients?

OBJECTIVE: Identification of the asymptomatic target organ damage (AOD) helps to stratify the overall risk of cardiovascular (CV) diseases and guides a treatment decision in hypertensive patients without a symptomatic CV or renal disease. The endothelial-cell-specific molecule 1 (endocan) is regarde...

Descripción completa

Detalles Bibliográficos
Autores principales: Ağaç, Mustafa Tarık, Kahyaoğlu, Behlül, Aksoy, Muhammed Murat Necati, Cinemre, Fatma Behice, Vatan, Mehmet Bülent, Gündüz, Yasemin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457429/
https://www.ncbi.nlm.nih.gov/pubmed/30694799
http://dx.doi.org/10.14744/AnatolJCardiol.2018.25564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457429/
https://www.ncbi.nlm.nih.gov/pubmed/30694799
http://dx.doi.org/10.14744/AnatolJCardiol.2018.25564

Ejemplares similares